Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries (vol 39, pg 3735, 2022)

被引：1
|
作者：
Fulcher, Gregory R. [1 ]
Akhtar, Shahid [2 ]
Al-Jaser, Saleh J. [3 ]
Medina, Johan [4 ]
Mohamed, Mafauzy [5 ]
Nicodemus, Nemencio A., Jr. [6 ]
Olsen, Anne Helene [4 ]
Singh, Kiran P. [7 ]
Kok, Adri [8 ,9 ]
机构：
[1] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia
[2] Novo Nordisk Reg Asia Pacific, Dubai, U Arab Emirates
[3] Specialized Med Ctr Hosp, Dept Internal Med, Riyadh, Saudi Arabia
[4] Novo Nordisk AS, Soborg, Denmark
[5] Hosp Univ Sains Malaysia, Dept Med, Kota Baharu, Kelantan, Malaysia
[6] Univ Philippines, Coll Med, Dept Biochem & Mol Biol, Manila, Philippines
[7] Fortis Hosp, Dept Endocrinol, Mohali, Punjab, India
[8] Netcare Union & Clinton Hosp, Alberton, South Africa
[9] Univ Witwatersrand, Johannesburg, South Africa
来源：
ADVANCES IN THERAPY | 2023年 / 40卷 / 01期
关键词：
D O I：
10.1007/s12325-022-02349-1
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：389 / 390
页数：2
相关论文
共 50 条
  • [1] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
    Fulcher, Gregory R.
    Akhtar, Shahid
    Al-Jaser, Saleh J.
    Medina, Johan
    Mohamed, Mafauzy
    Nicodemus, Nemencio A., Jr.
    Olsen, Anne Helene
    Singh, Kiran P.
    Kok, Adri
    [J]. ADVANCES IN THERAPY, 2022, 39 (08) : 3735 - 3748
  • [2] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
    Gregory R. Fulcher
    Shahid Akhtar
    Saleh J. Al-Jaser
    Johan Medina
    Mafauzy Mohamed
    Nemencio A. Nicodemus
    Anne Helene Olsen
    Kiran P. Singh
    Adri Kok
    [J]. Advances in Therapy, 2022, 39 : 3735 - 3748
  • [3] Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
    Gregory R. Fulcher
    Shahid Akhtar
    Saleh J. Al-Jaser
    Johan Medina
    Mafauzy Mohamed
    Nemencio A. Nicodemus
    Anne Helene Olsen
    Kiran P. Singh
    Adri Kok
    [J]. Advances in Therapy, 2023, 40 : 389 - 390
  • [4] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study
    Nicodemus Jr, Nemencio
    Ang-Golangco, Nerissa
    Aquitania, Grace
    Ardena, Gregory Joseph Ryan
    Dampil, Oliver Allan
    Fernando, Richard Elwyn
    Flor, Nicole-Therese
    Kho, Sjoberg
    Matawaran, Bien
    Mirasol, Roberto
    Panelo, Araceli
    Pasaporte, Francis
    Puno-Rocamora, Mercerose
    Shoeb, Ahsan
    Tolentino, Marsha
    [J]. JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2024,
  • [5] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes in Malaysia: Results from a Prospective, Non-interventional Real-World Study
    Mohamed, Mafauzy
    Lim, Siang Chin
    Mumtaz, Malik
    Uppal, Shweta
    Mukherjee, Deepak
    Kassim, Mohamed Saiful Mohd
    Sreedharan, Shalini
    Doraiswamy, Amudha Murugan
    Chong, Kuck Meng
    Tat, Lu Yu
    Nordin, Sudzilla Binti
    Giek, Jeshen Lau Hui
    Hussein, Zanariah
    Kadir, Khalid Abdul
    Lau, Bik Kui
    Chan, Siew Pheng
    [J]. JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (01): : 37 - 44
  • [6] Initiating or switching to insulin degludec/insulin aspart in a real-world population of adults with type 2 diabetes in Australia: results from a prospective, non-interventional study
    Fulcher, Gregory R.
    Cohen, Neale D.
    Davies, Katherine
    d'Emden, Michael
    Glastras, Sarah J.
    Mah, Peak M.
    McCallum, Roland W.
    Moses, Robert
    Thong, Ken Y.
    Roberts, Anthony
    [J]. INTERNAL MEDICINE JOURNAL, 2024,
  • [7] Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study
    Baruah, Manash P.
    Aneja, Pankaj
    Pitale, Shailesh
    Bhograj, Abhijit
    Agrawala, Ritesh K.
    Aggarwal, Ajay
    Mahadev, Prasad G.
    Madhavdas, Deepaklal C.
    Shah, Sanjay
    John, Mathew
    Pathan, Muzammil Khan. A.
    Revanna, Manjunatha
    Chandrappa, Manu
    Singh, Kiran P.
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (09) : 3590 - 3597
  • [8] FACTORS THAT AFFECT THE GLYCEMIC CONTROL ACHIEVED BY SWITCHING TO INSULIN DEGLUDEC/ASPART IN INSULIN-TREATED PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES IN A REAL-WORLD SETTING: A NON-INTERVENTIONAL, RETROSPECTIVE COHORT STUDY
    Onder, C. E.
    Kuskonmaz, S. M.
    Koc, G.
    Firat, S.
    Omma, T.
    Taskaldiran, I
    Gokbulut, P.
    Culha, C.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2020, 16 (04) : 443 - 448
  • [9] Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study—UPDATES Saudi Arabia
    Mussa H. AlMalki
    Hossam Aldesokey
    Dania Alkhafaji
    Abdulrahman Alsheikh
    Uffe Christian Braae
    Lars Lang Lehrskov
    Waleed Magawry
    Moataz Yahia
    Ahmed Haroun
    [J]. Advances in Therapy, 2023, 40 : 568 - 584
  • [10] ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design
    Gregory R. Fulcher
    Henrik Jarlov
    Johanne Spanggaard Piltoft
    Kiran Pal Singh
    Lei Liu
    Mafauzy Mohamed
    Nemencio Almare Nicodemus
    Saleh Jaser Al-Jaser
    Adri Kok
    [J]. Endocrine, 2021, 74 : 530 - 537
12345